Chong et al. [102] identified that CCL2 was not only increased in the tears of the topically medicated glaucoma patients in comparison to non-glaucomatous controls, but that patients with post-surgical failure within 6 months after surgery had higher levels of CCL2 at baseline in comparison to ‘successful’ glaucoma patients. This evidence concerns the gene CCL2 and glaucoma.